NCBP2-AS1: A Drug Target / Disease Biomarker (G100874001)

Target Name: NCBP2-AS1

NCBI ID: G100874001

NCBP2-AS1

Other Name(s): NCBP2 antisense RNA 1

NCBP2-AS1: A Drug Target / Disease Biomarker

The NCBP2-AS1 protein is a potential drug target and biomarker that is being studied for its role in the development and progression of various diseases, including cancer.

The NCBP2 gene is located on chromosome 18 and encodes for a protein that is involved in the regulation of cell proliferation and survival. The NCBP2 protein has been shown to play a role in the development and progression of various diseases, including cancer.

One of the key functions of the NCBP2 protein is its ability to promote the growth and survival of cancer cells. Studies have shown that high levels of the NCBP2 protein are associated with the development and progression of cancer.

In addition to its role in cancer development, the NCBP2 protein has also been shown to contribute to the development of other diseases and conditions, including cardiovascular disease and neurodegenerative disorders.

Despite the potential implications of the NCBP2 protein as a drug target, further research is needed to fully understand its role in the development and progression of disease. Researchers are currently studying the NCBP2 protein's effects on cancer cell growth and metastasis, as well as its potential interactions with other proteins that may be involved in disease progression.

The NCBP2-AS1 protein is a potential drug target and biomarker that is being studied for its role in the development and progression of various diseases. Further research is needed to fully understand its effects and potential as a drug.

Protein Name: NCBP2 Antisense RNA 1

The "NCBP2-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NCBP2-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets